• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in AI (Artificial Intelligence) In The Drug Discovery Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of AI (Artificial intelligence)  in the global drug discovery market looks promising with opportunities in pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic & government institutes. The AI in the global drug discovery market is expected to grow with a CAGR of 39% to 41% from 2021 to 2026. The major drivers for this market are growing pharmaceutical industry, high demand for personalized drug, rising adoption of cloud-based applications & services, growing number of cross-industry collaborations and partnerships, and increasing awareness of AI among drug manufacturers. 

A more than 150 page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of AI in drug discovery market report download the report brochure.

 

 

 
 
The study includes trends and forecasts for the global AI in drug discovery market by offering, drug type, technology, application, end use industry, and region as follows:

By Offering [$M shipment analysis for 2015 – 2026]:
  • Software
  • Services

By Drug Type [$M shipment analysis for 2015 – 2026]:
  • Small Molecules
  • Large Molecules

By Technology [$M shipment analysis for 2015 – 2026]:
  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Application [$M shipment analysis for 2015 – 2026]:
  • Immuno-Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Others

By End Use Industry [$M shipment analysis for 2015 – 2026]:
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers and Academic & Government Institutes

By Region [$M shipment analysis for 2015 – 2026]:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
  • The Rest of the World

Machine learning technology will remain the largest segment due to the capability to collect and handle big data and demand to improve productivity in many end use industries.  

Pharmaceutical & biotechnology companies will remain the largest end use industry during the forecast period due to high adoption of AI in the pharmaceutical industry, AI’s high accuracy to identify drug’s molecule binding properties, and increasing demand for drugs for complex conditions.

North America will remain the largest region during the forecast period due to high adoption of AI systems, growing pharmaceutical industry, and a large presence of AI manufacturers and the consumer market. 

Some of the AI in drug discovery companies profiled in this report include IBM, Microsoft, Google, NVIDIA, Atomwise, Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR , OWKIN, XtalPi, Verge Genomics, and BERG.


 
Features of AI in Drug Discovery Market
 
  • Market Size Estimates: AI in drug discovery market size estimation in terms of value ($M)
  • Trend and Forecast Analysis: Market trends (2015-2020) and forecast (2021-2026) by various segments and regions.
  • Segmentation Analysis: Market size by offering, drug type, technology, application, end use industry
  • Regional Analysis: AI in drug discovery market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different end use industries, offering, drug type, technology, application, and regions for AI in drug discovery market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the AI in drug discovery market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following 11 key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for AI in the global drug discovery market by offering (software, services), drug type (small molecule, large molecules), technology (machine learning (deep learning, supervised learning, reinforcement learning, unsupervised learning, and others) and others technologies), application (immuno-oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, and others), end user industry (pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic & government institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges for AI in the drug discovery market?
Q.5 What are the business risks and threats to AI in the drug discovery market?
Q.6 What are emerging trends of AI in the drug discovery market and the reasons behind them?
Q.7 What are some changing demands of customers for AI in the drug discovery market?
Q.8 What are the new developments in AI in the drug discovery market? Which companies are leading these developments?
Q.9 Who are the major AI players in the drug discovery market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes of AI in the drug discovery market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years for AI in the drug discovery market?

Table of Contents

 
  1. Executive Summary
  2. Market Background and Classifications
    • Introduction, Background, and Classifications
    • Supply Chain
    • Industry Drivers and Challenges
  3. Market Trends and Forecast Analysis from 2015 to 2026
    • Macroeconomic Trends (2015-2020) and Forecast (2021-2026)
    • Global AI in Drug Discovery Market Trends (2015-2020) and Forecast (2021-2026)
    • Global AI in Drug Discovery Market by End Use Industry
      • Pharmaceutical & Biotechnology Companies
      • Contract Research Organizations
      • Research Centers and Academic & Government Institutes
    • Global AI in Drug Discovery Market by Application
      • Immuno-oncology
      • Neurodegenerative Diseases
      • Cardiovascular Diseases
      • Metabolic Diseases
      • Others
    • Global AI in Drug Discovery Market by Technology
      • Machine Learning
      • Deep Learning
      • Supervised Learning
      • Reinforcement Learning
      • Unsupervised Learning
      • Other Machine Learning Technologies
      • Others
    • Global AI in Drug Discovery Market by Drug Type
      • Small Molecule
      • Large Molecules
    • Global AI in Drug Discovery Market by Offering
      • Software
      • Services
  4. Market Trends and Forecast Analysis by Region from 2015 to 2026
    • Global AI in Drug Discovery Market by Region
    • North American AI in Drug Discovery Market
      • Market by End Use Industry
      • Market by Application
      • Market by Technology
      • The US AI in Drug Discovery Market
      • The Canadian AI in Drug Discovery Market
      • The Mexican AI in Drug Discovery Market
    • European AI in Drug Discovery Market
      • Market by End Use Industry
      • Market by Application
      • Market by Technology
      • German AI in Drug Discovery Market
      • United Kingdom AI in Drug Discovery Market
      • French AI in Drug Discovery Market
      • Italian AI in Drug Discovery Market
    • APAC AI in Drug Discovery Market
      • Market by End Use Industry
      • Market by Application
      • Market by Technology
      • Chinese AI in Drug Discovery Market
      • Japanese AI in Drug Discovery Market
      • Indian AI in Drug Discovery Market
      • South Korean AI in Drug Discovery Market
    • ROW AI in Drug Discovery Market
      • Market by End Use Industry
      • Market by Application
      • Market by Technology
  5. Competitor Analysis
    • Product Portfolio Analysis
    • Geographical Reach
    • Porter’s Five Forces Analysis
  6. Growth Opportunities and Strategic Analysis
    • Growth Opportunity Analysis
      • Growth Opportunities for the Global AI in Drug Discovery Market by End Use Industry
      • Growth Opportunities for the Global AI in Drug Discovery Market by Application
      • Growth Opportunities for the Global AI in Drug Discovery Market by Technology
      • Growth Opportunities for the Global AI in Drug Discovery Market by Drug Type
      • Growth Opportunities for the Global AI in Drug Discovery Market by Offering
      • Growth Opportunities for the Global AI in Drug Discovery Market by Region
    • Emerging Trends in the Global AI in Drug Discovery Market
    • Strategic Analysis
      • New Product Development
      • Capacity Expansion of the Global AI in Drug Discovery Market
      • Technology Development
      • Mergers and Acquisitions in the Global AI in Drug Discovery Industry
  7. Company Profiles of Leading Players
    • IBM
    • Microsoft
    • Google
    • NVIDIA
    • Atomwise
    • Deep Genomics
    • Cloud Pharmaceuticals
    • Insilico Medicine
    • BenevolentAI
    • Exscientia
    • Cyclica
    • BIOAGE
    • Numerate
    • NuMedii
    • Envisagenics
    • twoXAR
    • OWKIN
    • XtalPi
    • Verge Genomics
    • BERG

.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: AI (Artificial Intelligence) In The Global Drug Discovery Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.
 

 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.